Gastro-oesophageal Reflux Disease Trial, Recruiting NCT05330910 Sponsor: Sengkang General Hospital Condition: Gastro-oesophageal Reflux Disease
Back to Gord

Gastro-oesophageal Reflux Disease Trial, Recruiting

NCT05330910
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People between 21 and 65 years old
  • People who are able and willing to give their formal agreement to take part in the study
  • People whose pre-surgery camera examination of the throat and stomach showed a specific finding called "Hill's grade III" at the junction between the food pipe and stomach
  • People who have chosen to have a type of weight-loss surgery called laparoscopic sleeve gastrectomy (where part of the stomach is removed using keyhole surgery)

Who may not be able to join:

  • People who are unable or unwilling to give their formal agreement to take part in the study
  • People for whom laparoscopic sleeve gastrectomy is medically unsuitable for any reason
  • People who have not chosen to have laparoscopic sleeve gastrectomy as their weight-loss procedure
  • People who have had previous surgery on the upper part of the digestive system (such as the stomach or food pipe)
  • People whose pre-surgery camera examination showed irritation or damage to the lining of the food pipe (erosive esophagitis)
  • People whose pre-surgery camera examination showed a result other than Hill's grade III at the junction between the food pipe and stomach (specifically grade I, II, or IV)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Baldwin Po Man Yeung, MBChB, FRCS, Sengkang General Hospital

Phone: +65 91196091

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Sengkang General Hospital
Registry
ClinicalTrials.gov
Start date
1 April 2022
Est. completion
30 April 2027

Where this trial is recruiting

🇸🇬 Singapore

Primary endpoints

Presence or absence of post-operative erosive esophagitis; Degree of Post-operative erosive esophagitis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov